Status | Study |
Recruiting |
Study Name: Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) Condition: Hypogonadotropic Hypogonadism Date: 2017-01-11 Interventions: Drug: Corifollitropin alfa Cor |
Recruiting |
Study Name: Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ Condition: Hypogonadism Date: 2016-10-17 Interventions: Drug: NATESTO Testosterone Nasal Gel Participants will be |
Recruiting |
Study Name: Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Condition: Male Hypogonadism Date: 2016-09-26 Interventions: Drug: DITEST Lipid formulation |
Completed |
Study Name: Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism Condition: Idiopathic Hypogonadotropic Hypogonadism Date: 2016-03-27 Interventions: Drug: human chorionic gonadotropin, human menopausal gonadotropin drug for the treatment of male hypogon |
Recruiting |
Study Name: Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotrophic Hypogonadism Condition: Hypogonadotropic Hypogonadism Date: 2016-03-17 Interventions: Drug: BGS649 Capsules will be |
Completed |
Study Name: Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY) Condition: Hypogonadism Date: 2015-07-20 Interventions: Drug: Testosterone enanthate auto-injector Dose Adjustment 100 mg / 75 mg / 50 mg |
Terminated |
Study Name: A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism Condition: Hypogonadotropic Hypogonadism Date: 2015-02-17 Interventions: Drug: TAK-448 TAK-448 solution for subcutaneous injection |
Completed |
Study Name: Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism Condition: Hypogonadism Date: 2014-06-06 Interventions: Drug: Testosterone enanthate auto-injector Dose Adjustment 100 mg / 75 mg / 50 mg |
Completed |
Study Name: The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism Condition: Hypogonadism Date: 2014-04-07 Interventions: Drug: Testosterone Testosterone 250 mg injection per 3-4 weeks for 6 months |
Completed |
Study Name: Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment Condition: Hypogonadism Date: 2014-04-05 Interventions: Drug: Testosterone Testosterone 250 mg injection per 3-4 weeks for 6 months |